Calcipotriene And Betamethasone Dipropionate Ointment
Product Images NDC 66993-938

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Calcipotriene And Betamethasone Dipropionate (NDC 66993-938). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Calcipotriene 01)

FDA Label Image

Chemical Structure (Calcipotriene 02)

FDA Label Image

Principal Display Panel (60 g Tube Carton)

Principal Display Panel (60 g Tube Carton)
This is a pharmaceutical ointment containing calcipotriene hydrate and betamethasone dipropionate. It is intended to be applied topically as directed by a physician, for conditions that the physician deems treatable by this medication. The ointment should be stored within a temperature range of 20°C to 25°C (68°F to 77°F). It is distributed by Prasco Laboratories and the manufacturer is LEO Laboratories L, based in Dublin, Ireland.*
FDA Label Image

Calcipotriene 04

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.